It has been demonstrated that central obesity, clinically expressed as elevated waist circumference, is characterized by reduced insulin sensitivity that in turn leads to free fatty acid flux to the liver with increased release of lipoprotein rich in triglycerides [28]; moreover, abnormal activity of adipocyte in central obesity leads to enhanced subclinical inflammation that is strongly associated with insulin resistance [29,30]. Here, INS is linked to Abdominal obesity.